UFMylation promotes orthoflavivirus infectious particle production

Hannah M Schmidt1, Grace C Sorensen2, Matthew R Lanahan2

  • 1Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.

Journal of Virology
|June 3, 2025
PubMed

Insights

UFMylation, a protein modification, is essential for orthoflavivirus infection by promoting viral assembly. This pathway is crucial for viruses like dengue and Zika but not hepatitis C virus, offering new therapeutic targets.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Post-translational modifications regulate viral infections, but many remain uncharacterized in orthoflaviviruses.
  • The UFMylation system, involving UFM1 conjugation, is a key cellular process.

Purpose of the Study:

  • To investigate the role of the UFMylation system in orthoflavivirus replication and virion production.
  • To identify specific mechanisms by which UFMylation influences viral infection.

Main Methods:

  • Depletion of UFMylation machinery components (UFL1, UFBP1, UBA5, UFC1, UFM1) using genetic approaches.
  • Assessing orthoflavivirus (DENV, ZIKV) and hepacivirus (HCV) infectious virion production.
  • Identifying protein-protein interactions between UFMylation factors and viral proteins.

Main Results:

  • Depletion of UFMylation components significantly reduced infectious orthoflavivirus production.
  • UFMylation's role was specific to orthoflaviviruses, not affecting hepatitis C virus.
  • UFMylation was found to be critical for viral assembly, not translation, replication, or egress.
  • Novel interactions were identified between UFL1 and orthoflavivirus assembly proteins (NS2A, NS2B-NS3, capsid).

Conclusions:

  • UFMylation is a previously unrecognized post-translational modification pathway that promotes orthoflavivirus infection.
  • This pathway specifically modulates viral assembly, highlighting its importance in the viral life cycle.
  • UFMylation machinery represents a potential therapeutic target for orthoflavivirus infections.